Safety alert for transdermal patches.
D000279:Administration, Cutaneous; D000535:Aluminum / Q000009:adverse effects*; D004337:Drug Carriers / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging; D011358:Product Surveillance, Postmarketing; D012449:Safety
D004337:Drug Carriers; D000535:Aluminum